Cubist Systematic Strategies LLC lifted its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 212.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 48,900 shares of the pharmacy operator’s stock after acquiring an additional 33,238 shares during the period. Cubist Systematic Strategies LLC’s holdings in Walgreens Boots Alliance were worth $3,776,000 at the end of the most recent quarter.
Several other hedge funds also recently modified their holdings of the company. Vanguard Group Inc. grew its position in Walgreens Boots Alliance by 2.8% in the second quarter. Vanguard Group Inc. now owns 69,985,653 shares of the pharmacy operator’s stock valued at $5,480,577,000 after purchasing an additional 1,926,108 shares in the last quarter. Franklin Resources Inc. grew its position in Walgreens Boots Alliance by 24.7% in the second quarter. Franklin Resources Inc. now owns 18,502,701 shares of the pharmacy operator’s stock valued at $1,448,939,000 after purchasing an additional 3,662,302 shares in the last quarter. Nordea Investment Management AB grew its position in Walgreens Boots Alliance by 1.0% in the third quarter. Nordea Investment Management AB now owns 10,182,388 shares of the pharmacy operator’s stock valued at $786,284,000 after purchasing an additional 96,552 shares in the last quarter. Dimensional Fund Advisors LP grew its position in Walgreens Boots Alliance by 12.5% in the third quarter. Dimensional Fund Advisors LP now owns 6,641,826 shares of the pharmacy operator’s stock valued at $512,893,000 after purchasing an additional 735,917 shares in the last quarter. Finally, CI Global Investments Inc. grew its position in Walgreens Boots Alliance by 4.8% in the second quarter. CI Global Investments Inc. now owns 5,931,592 shares of the pharmacy operator’s stock valued at $464,503,000 after purchasing an additional 270,182 shares in the last quarter. 61.18% of the stock is owned by institutional investors.
Shares of Walgreens Boots Alliance Inc (WBA) opened at $76.07 on Friday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.47 and a current ratio of 0.96. The stock has a market cap of $75,340.00, a PE ratio of 21.01, a PEG ratio of 1.29 and a beta of 1.22. Walgreens Boots Alliance Inc has a 12 month low of $63.82 and a 12 month high of $88.00.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.27 by $0.01. The company had revenue of $30.74 billion during the quarter, compared to analysts’ expectations of $30.39 billion. Walgreens Boots Alliance had a net margin of 3.19% and a return on equity of 19.15%. Walgreens Boots Alliance’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same quarter last year, the company posted $1.10 EPS. research analysts forecast that Walgreens Boots Alliance Inc will post 5.59 earnings per share for the current year.
Walgreens Boots Alliance announced that its board has initiated a share repurchase program on Wednesday, October 25th that authorizes the company to buyback $1.00 billion in shares. This buyback authorization authorizes the pharmacy operator to reacquire shares of its stock through open market purchases. Stock buyback programs are often an indication that the company’s board believes its stock is undervalued.
A number of research analysts recently weighed in on WBA shares. Pivotal Research decreased their target price on shares of Walgreens Boots Alliance from $85.00 to $73.00 and set a “hold” rating for the company in a research report on Tuesday, October 24th. Needham & Company LLC reaffirmed a “buy” rating and issued a $94.00 target price on shares of Walgreens Boots Alliance in a research report on Thursday, October 12th. Deutsche Bank started coverage on shares of Walgreens Boots Alliance in a research report on Monday, December 4th. They issued a “hold” rating and a $78.00 target price for the company. Vetr upgraded shares of Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, December 12th. Finally, Royal Bank of Canada reiterated a “buy” rating and issued a $88.00 price target on shares of Walgreens Boots Alliance in a research note on Wednesday, October 25th. Nine research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $86.15.
In related news, Director John Anthony Lederer bought 20,000 shares of the business’s stock in a transaction dated Thursday, October 26th. The stock was bought at an average price of $67.00 per share, for a total transaction of $1,340,000.00. Following the purchase, the director now owns 50,000 shares in the company, valued at approximately $3,350,000. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction dated Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total transaction of $184,324.32. Following the sale, the director now owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The disclosure for this sale can be found here. Company insiders own 14.80% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “Cubist Systematic Strategies LLC Raises Stake in Walgreens Boots Alliance Inc (WBA)” was originally published by Stock Observer and is the sole property of of Stock Observer. If you are accessing this news story on another domain, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright law. The original version of this news story can be read at https://www.thestockobserver.com/2018/01/13/cubist-systematic-strategies-llc-raises-stake-in-walgreens-boots-alliance-inc-wba.html.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.